Cargando…
Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280167/ https://www.ncbi.nlm.nih.gov/pubmed/37347042 http://dx.doi.org/10.3389/fmolb.2023.1190116 |
| _version_ | 1785060744958574592 |
|---|---|
| author | Cao, Chenxi Chen, Shuang Wang, Libo Liu, Zaoqu Han, Xinwei |
| author_facet | Cao, Chenxi Chen, Shuang Wang, Libo Liu, Zaoqu Han, Xinwei |
| author_sort | Cao, Chenxi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10280167 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102801672023-06-21 Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers Cao, Chenxi Chen, Shuang Wang, Libo Liu, Zaoqu Han, Xinwei Front Mol Biosci Molecular Biosciences Frontiers Media S.A. 2023-06-06 /pmc/articles/PMC10280167/ /pubmed/37347042 http://dx.doi.org/10.3389/fmolb.2023.1190116 Text en Copyright © 2023 Cao, Chen, Wang, Liu and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Molecular Biosciences Cao, Chenxi Chen, Shuang Wang, Libo Liu, Zaoqu Han, Xinwei Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title | Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title_full | Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title_fullStr | Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title_full_unstemmed | Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title_short | Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| title_sort | editorial: using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers |
| topic | Molecular Biosciences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280167/ https://www.ncbi.nlm.nih.gov/pubmed/37347042 http://dx.doi.org/10.3389/fmolb.2023.1190116 |
| work_keys_str_mv | AT caochenxi editorialusingmultiomicstodevelopnewstrategiestoimproveprognosisandimmunotherapyoutcomesincancers AT chenshuang editorialusingmultiomicstodevelopnewstrategiestoimproveprognosisandimmunotherapyoutcomesincancers AT wanglibo editorialusingmultiomicstodevelopnewstrategiestoimproveprognosisandimmunotherapyoutcomesincancers AT liuzaoqu editorialusingmultiomicstodevelopnewstrategiestoimproveprognosisandimmunotherapyoutcomesincancers AT hanxinwei editorialusingmultiomicstodevelopnewstrategiestoimproveprognosisandimmunotherapyoutcomesincancers |